oncology

Gilead Oncology’s brand refresh takes back the possibilities cancer steals
Gilead Oncology’s brand refresh takes back the possibilities cancer steals
Medical Marketing and Media
Gilead Oncology
branding
oncology
cancer
Flag link:
Alkermes Spins Off Oncology Business with $275M to Focus on Neuroscience
Alkermes Spins Off Oncology Business with $275M to Focus on Neuroscience
BioSpace
Alkermes
spinoffs
oncology
Mural Oncology
NASDAQ
Flag link:
FDA's oncology office uses advisory committee to spotlight timely accelerated approval confirmation
FDA's oncology office uses advisory committee to spotlight timely accelerated approval confirmation
Fierce Pharma
FDA
regulatory
oncology
cancer
accelerated approvals
Acrotech Biopharma
Flag link:
Bayer adds a new life science incubator in China
Bayer adds a new life science incubator in China
Pharmaphorum
Bayer
Co.Lab
incubators
China
oncology
cell therapy
gene therapy
Flag link:
Moderna, Caris Life Team Up to Advance mRNA-Based Oncology Therapeutics
Moderna, Caris Life Team Up to Advance mRNA-Based Oncology Therapeutics
Marketwatch
Moderna Therapeutics
Caris Life Sciences
oncology
cancer
MRNA
Flag link:
ESMO: AstraZeneca aims for ‘2.0’ cancer pipeline, shares bispecific data
ESMO: AstraZeneca aims for ‘2.0’ cancer pipeline, shares bispecific data
Fierce Biotech
AstraZeneca
cancer
oncology
bispecifics
Flag link:
Merck discontinues some cancer drug development with China's Sichuan Kelun
Merck discontinues some cancer drug development with China's Sichuan Kelun
Reuters
Merck
Sichuan Kelun Pharmaceutical
cancer
oncology
Flag link:
Charles River offers clients new database for pediatric oncology research
Charles River offers clients new database for pediatric oncology research
Biopharma Reporter
Charles River Labs
oncology
pediatric
cancer
data
Flag link:
ESMO: Rain in Spain doesn’t dampen spirits of 33,000 oncologists
ESMO: Rain in Spain doesn’t dampen spirits of 33,000 oncologists
Fierce Pharma
ESMO
oncology
cancer
Europe
conferences
Flag link:
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
CP Wire/Businesswire
Bristol Myers Squibb
M&A
Mirati Therapeutics
oncology
cancer
Krazati
Flag link:
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Bristol Myers Squibb
M&A
Mirati Therapeutics
oncology
Flag link:
Lilly Deepens Oncology Pipeline with $1.4B Point Biopharma Purchase
Lilly Deepens Oncology Pipeline with $1.4B Point Biopharma Purchase
BioSpace
Eli Lilly
oncology
M&A
Point Biopharma
radioligand
Flag link:
Amgen unveils Partners of Choice oncology network
Amgen unveils Partners of Choice oncology network
Medical Marketing and Media
Amgen
expert panels
oncology
cancer
Flag link:
White House announces plan to tackle cancer drug supply issues
White House announces plan to tackle cancer drug supply issues
10news.com
cancer
oncology
drug shortages
Joe Biden
Flag link:
Immuneering takes aim at cancer’s ‘superhighway’
Immuneering takes aim at cancer’s ‘superhighway’
Pharma Voice
Immuneering
Neuroscience
cancer
oncology
RAS
Flag link:
Mariana Oncology Announces $175 Million Series B Financing
Mariana Oncology Announces $175 Million Series B Financing
BioSpace
Mariana Oncology
oncology
funding
Flag link:
Radiopharmaceuticals for cancer: Making radiation precise
Radiopharmaceuticals for cancer: Making radiation precise
BioPharma Dive
radiopharmaceuticals
cancer
oncology
Rayze Bio
ITM
Aktis Oncology
Abdera Therapeutics
Convergent Therapeutics
Precirix
Alpha-9 Theranostics
Mariana Oncology
Ariceum Therapeutics
Ratio Therapeutics
Radionetics Oncology
Artbio
Flag link:
Gilead inks $66M+ deal with Tentarix in oncology, inflammatory diseases
Gilead inks $66M+ deal with Tentarix in oncology, inflammatory diseases
Fierce Biotech
Tentarix Biotherapeutics
Gilead Sciences
oncology
inflammatory disease
Flag link:
US pharmacists say drug shortages are affecting cancer care
US pharmacists say drug shortages are affecting cancer care
Pharmaphorum
cancer
oncology
drug shortages
Flag link:
Daiichi Sankyo will remain 'dominant' in ADC market for oncology treatments
Daiichi Sankyo will remain 'dominant' in ADC market for oncology treatments
Biopharma Reporter
Daiichi Sankyo
antibody drug conjugate
oncology
Seagen
Roche
Flag link:

Pages